<?xml version="1.0" encoding="UTF-8"?>
<ref id="B30-pharmaceutics-11-00231" class="ref">
 <label class="label">30.</label>
 <element-citation publication-type="journal" class="element-citation">
  <person-group person-group-type="author" class="person-group">
   <name class="name">
    <surname class="surname">Severino</surname>
    <given-names class="given-names">P.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Andreani</surname>
    <given-names class="given-names">T.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Jager</surname>
    <given-names class="given-names">A.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Chaud</surname>
    <given-names class="given-names">M.V.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Santana</surname>
    <given-names class="given-names">M.H.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Silva</surname>
    <given-names class="given-names">A.M.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Souto</surname>
    <given-names class="given-names">E.B.</given-names>
   </name>
  </person-group>
  <article-title class="article-title">Solid Lipid Nanoparticles for Hydrophilic Biotech Drugs: Optimization and Cell Viability Studies (Caco-2 &amp; Hepg-2 Cell Lines)</article-title>
  <source class="source">Eur. J. Med. Chem.</source>
  <year class="year">2014</year>
  <volume class="volume">81</volume>
  <fpage class="fpage">28</fpage>
  <lpage class="lpage">34</lpage>
  <pub-id pub-id-type="doi" class="pub-id">10.1016/j.ejmech.2014.04.084</pub-id>
  <pub-id pub-id-type="pmid" class="pub-id">24819957</pub-id>
 </element-citation>
</ref>
